Mesenchymal stem cell graft improves recovery after spinal cord injury in adult rats through neurotrophic and pro-angiogenic actions

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Quertainmont, Renaud ^a   Cantinieaux, Dorothée ^a   Botman, Olivier ^a   Sid, Selim ^a   Schoenen, Jean ^a   Franzen, Rachelle ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; BROXURIDINE; CYTOKINE; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR;

ADULT ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FATE; CELL LABELING; CELL VIABILITY; CONTROLLED STUDY; FEMALE; FUNCTIONAL ASSESSMENT; HISTOPATHOLOGY; MESENCHYMAL STEM CELL TRANSPLANTATION; NERVE FIBER GROWTH; NEUROPROTECTION; NONHUMAN; OPEN FIELD TEST; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MICROARRAY; RAT; SPINAL CORD COMPRESSION; THERAPY EFFECT; UPREGULATION; VASCULARIZATION;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; FEMALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; RATS; RATS, WISTAR; SPINAL CORD INJURIES;

EID: 84862638483     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039500     Document Type: Article

References (90)

1. McDonald JW, Sadowsky C, (2002) Spinal-cord injury. The Lancet 359: 417-425.
2. Nishio T, (2009) Axonal regeneration and neural network reconstruction in mammalian CNS. Journal of Neurology 256: 306-309.
3. Webb AA, Ngan S, Fowler JD, (2010) Spinal cord injury I: A synopsis of the basic science. Canadian Veterinary Journal 51: 485-492.
4. Wright KT, Masri WE, Osman A, Chowdhury J, Johnson WEB, (2011) Concise Review: Bone Marrow for the Treatment of Spinal Cord Injury: Mechanisms and Clinical Applications. Stem Cells 29: 169-178.
5. Coutts M, Keirstead HS, (2008) Stem cells for the treatment of spinal cord injury. Exp Neurol 209: 368-377.
6. Reier PJ, (2004) Cellular transplantation strategies for spinal cord injury and translational neurobiology. NeuroRx 1: 424-451.
7. Honmou O, Felts PA, Waxman SG, Kocsis JD, (1996) Restoration of normal conduction properties in demyelinated spinal cord axons in the adult rat by transplantation of exogenous Schwann cells. Journal of Neuroscience 16: 3199-3208.
8. Martin D, Robe P, Franzen R, Delree P, Schoenen J, et al. (1996) Effects of Schwann cell transplantation in a contusion model of rat spinal cord injury. Journal of Neuroscience Research 45: 588-597.
9. Li BC, Li Y, Chen LF, Chang JY, Duan ZX, (2011) Olfactory ensheathing cells can reduce the tissue loss but not the cavity formation in contused spinal cord of rats. Journal of the Neurological Sciences 303: 67-74.
10. Raisman G, (2007) Repair of spinal cord injury by transplantation of olfactory ensheathing cells. C R Biol 330: 557-560.
11. Schultz SS, (2005) Adult stem cell application in spinal cord injury. Curr Drug Targets 6: 63-73.
12. Tarasenko YI, Gao J, Nie L, Johnson KM, Grady JJ, et al. (2007) Human fetal neural stem cells grafted into contusion-injured rat spinal cords improve behavior. Journal of Neuroscience Research 85: 47-57.
13. Osaka M, Honmou O, Murakami T, Nonaka T, Houkin K, et al. (2010) Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome. Brain Research 1343: 226-235.
14. Chopp M, Zhang XH, Li Y, Wang L, Chen J, et al. (2000) Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. Neuroreport 11: 3001-3005.
15. Franzen R, Martin D, Daloze A, Moonen G, Schoenen J, (1999) Grafts of meningeal fibroblasts in adult rat spinal cord lesion promote axonal regrowth. Neuroreport 10: 1551-1556.
16. Tobias CA, Shumsky JS, Shibata M, Tuszynski MH, Fischer I, et al. (2003) Delayed grafting of BDNF and NT-3 producing fibroblasts into the injured spinal cord stimulates sprouting, partially rescues axotomized red nucleus neurons from loss and atrophy, and provides limited regeneration. Experimental Neurology 184: 97-113.
17. Franzen R, Schoenen J, Leprince P, Joosten E, Moonen G, et al. (1998) Effects of macrophage transplantation in the injured adult rat spinal cord: A combined immunocytochemical and biochemical study. Journal of Neuroscience Research 51: 316-327.
18. Barry FP, Murphy JM, (2004) Mesenchymal stem cells: clinical applications and biological characterization. The International Journal of Biochemistry & Cell Biology 36: 568-584.
19. Augello A, Kurth TB, De Bari C, (2010) Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches. Eur Cell Mater 20: 121-133.
20. Caplan AI, Dennis JE, (2006) Mesenchymal stem cells as trophic mediators. Journal of Cellular Biochemistry 98: 1076-1084.
21. da Silva Meirelles L, Fontes AM, Covas DT, Caplan AI, (2009) Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine & Growth Factor Reviews 20: 419-427.
22. Uccelli A, Benvenuto F, Laroni A, Giunti D, (2011) Neuroprotective features of mesenchymal stem cells. Best Practice & Research Clinical Haematology 24: 59-64.
23. Poll D, Parekkadan B, Borel Rinkes IHM, Tilles AW, Yarmush ML, (2008) Mesenchymal Stem Cell Therapy for Protection and Repair of Injured Vital Organs. Cellular and Molecular Bioengineering 1: 42-50.
24. Wislet-Gendebien S, Hans G, Leprince P, Rigo J-M, Moonen G, et al. (2005) Plasticity of Cultured Mesenchymal Stem Cells: Switch from Nestin-Positive to Excitable Neuron-Like Phenotype. Stem Cells 23: 392-402.
25. Krampera M, Marconi S, Pasini A, Galiè M, Rigotti G, et al. (2007) Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus. Bone 40: 382-390.
26. Jin K, Mao XO, Batteur S, Sun Y, Greenberg DA, (2003) Induction of neuronal markers in bone marrow cells: differential effects of growth factors and patterns of intracellular expression. Exp Neurol 184: 78-89.
27. Greco SJ, Zhou C, Ye JH, Rameshwar P, (2008) A method to generate human mesenchymal stem cell-derived neurons which express and are excited by multiple neurotransmitters. Biol Proced Online 10: 90-101.
28. Wang TT, Tio M, Lee W, Beerheide W, Udolph G, (2007) Neural differentiation of mesenchymal-like stem cells from cord blood is mediated by PKA. Biochem Biophys Res Commun 357: 1021-1027.
29. Xu H, Miki K, Ishibashi S, Inoue J, Sun L, et al. (2010) Transplantation of neuronal cells induced from human mesenchymal stem cells improves neurological functions after stroke without cell fusion. J Neurosci Res 88: 3598-3609.
30. Kishk NA, Gabr H, Hamdy S, Afifi L, Abokresha N, et al. (2010) Case Control Series of Intrathecal Autologous Bone Marrow Mesenchymal Stem Cell Therapy for Chronic Spinal Cord Injury. Neurorehabilitation and Neural Repair 24: 702-708.
31. Roussos I, Rodriguez M, Villán D, Ariza A, Rodriguez L, et al. (2005) Development of a Rat Model of Spinal Cord Injury and Cellular Transplantation. Transplantation Proceedings 37: 4127-4130.
32. Ra JC, Shin IS, Kim SH, Kang SK, Kang BC, et al. (2011) Safety of Intravenous Infusion of Human Adipose Tissue-Derived Mesenchymal Stem Cells in Animals and Humans. Stem Cells and Development.
33. Karussis D, Karageorgiou C, Vaknin-Dembinsky A, Gowda-Kurkalli B, Gomori JM, et al. (2010) Safety and Immunological Effects of Mesenchymal Stem Cell Transplantation in Patients With Multiple Sclerosis and Amyotrophic Lateral Sclerosis. Archives of Neurology 67: 1187-1194.
34. Quirici N, Soligo D, Bossolasco P, Servida F, Lumini C, et al. (2002) Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 30: 783-791.
35. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
36. Wislet-Gendebien S, Laudet E, Neirinckx V, Alix P, Leprince P, et al. (2012) Mesenchymal stem cells and neural crest stem cells from adult bone marrow: characterization of their surprising similarities and differences. Cell Mol Life Sciences (DOI: 10.1007/s00018-012-0937-1).
37. Tetzlaff W, Okon EB, Karimi-Abdolrezaee S, Hill CE, Sparling JS, et al. (2011) A systematic review of cellular transplantation therapies for spinal cord injury. J Neurotrauma 28: 1611-1682.
38. Urdzikova L, Jendelova P, Glogarova K, Burian M, Hajek M, et al. (2006) Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promotes recovery after spinal cord injury in rats. J Neurotrauma 23: 1379-1391.
39. Li ZH, Liao W, Cui XL, Zhao Q, Liu M, et al. (2011) Intravenous transplantation of allogeneic bone marrow mesenchymal stem cells and its directional migration to the necrotic femoral head. Int J Med Sci 8: 74-83.
40. Lu D, Mahmood A, Wang L, Li Y, Lu M, et al. (2001) Adult bone marrow stromal cells administered intravenously to rats after traumatic brain injury migrate into brain and improve neurological outcome. Neuroreport 12: 559-563.
41. Karp JM, Teo GSL, (2009) Mesenchymal stem cell homing: the devil is in the details. Cell stem cell 4: 206-216.
42. Takeuchi H, Natsume A, Wakabayashi T, Aoshima C, Shimato S, et al. (2007) Intravenously transplanted human neural stem cells migrate to the injured spinal cord in adult mice in an SDF-1- and HGF-dependent manner. Neurosci Lett 426: 69-74.
43. Iihoshi S, Honmou O, Houkin K, Hashi K, Kocsis JD, (2004) A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats. Brain Res 1007: 1-9.
44. Parr AM, Tator CH, Keating A, (2007) Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplantation 40: 609-619.
45. Paul C, Samdani AF, Betz RR, Fischer I, Neuhuber B, (2009) Grafting of human bone marrow stromal cells into spinal cord injury: a comparison of delivery methods. Spine (Phila Pa 1976) 34: 328-334.
46. Takahashi Y, Tsuji O, Kumagai G, Hara CM, Okano HJ, et al. (2010) Comparative study of methods for administering neural stem/progenitor cells to treat spinal cord injury in mice. Cell Transplantation.
47. Sykova E, Homola A, Mazanec R, Lachmann H, Konradova SL, et al. (2006) Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplant. 15: 675-687.
48. Kordower JH, Isacson O, Emerich DF, (1999) Cellular Delivery of Trophic Factors for the Treatment of Huntington's Disease: Is Neuroprotection Possible? Experimental Neurology 159: 4-20.
49. Cao Q, He Q, Wang Y, Cheng X, Howard RM, et al. (2010) Transplantation of ciliary neurotrophic factor-expressing adult oligodendrocyte precursor cells promotes remyelination and functional recovery after spinal cord injury. Journal of Neuroscience 30: 2989-3001.
50. Deshmane SL, Kremlev S, Amini S, Sawaya BE, (2009) Monocyte chemoattractant protein-1 (MCP-1): an overview. Journal of Interferon and Cytokine Research 29: 313-326.
51. Ousman SS, David S, (2001) MIP-1alpha, MCP-1, GM-CSF, and TNF-alpha control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord. Journal of Neuroscience 21: 4649-4656.
52. Huang X, Choi J-K, Park SR, Ha Y, Park H, et al. (2007) GM-CSF inhibits apoptosis of neural cells via regulating the expression of apoptosis-related proteins. Neuroscience Research 58: 50-57.
53. Huang X, Kim J-M, Kong TH, Park SR, Ha Y, et al. (2009) GM-CSF inhibits glial scar formation and shows long-term protective effect after spinal cord injury. Journal of the Neurological Sciences 277: 87-97.
54. Bouhy D, Malgrange B, Multon S, Poirrier AL, Scholtes F, et al. (2006) Delayed GM-CSF treatment stimulates axonal regeneration and functional recovery in paraplegic rats via an increased BDNF expression by endogenous macrophages. FASEB Journal 20: 1239-1241.
55. Luo J, Zhang HT, Jiang XD, Xue S, Ke YQ, (2009) Combination of bone marrow stromal cell transplantation with mobilization by granulocyte-colony stimulating factor promotes functional recovery after spinal cord transection. Acta Neurochir (Wien) 151: 1483-1492.
56. Mahmood A, Lu D, Chopp M, (2004) Intravenous administration of marrow stromal cells (MSCs) increases the expression of growth factors in rat brain after traumatic brain injury. J Neurotrauma 21: 33-39.
57. Sofroniew MV, Howe CL, Mobley WC, (2001) Nerve growth factor signaling, neuroprotection, and neural repair. Annual Review of Neuroscience 24: 1217-1281.
58. Pettigrew DB, Li YQ, Kuntz Ct, Crutcher KA, (2007) Global expression of NGF promotes sympathetic axonal growth in CNS white matter but does not alter its parallel orientation. Experimental Neurology 203: 95-109.
59. Nguyen TL, Kim CK, Cho JH, Lee KH, Ahn JY, (2010) Neuroprotection signaling pathway of nerve growth factor and brain-derived neurotrophic factor against staurosporine induced apoptosis in hippocampal H19-7/IGF-IR. Experimental and Molecular Medicine 42: 583-595.
60. Munoz JR, Stoutenger BR, Robinson AP, Spees JL, Prockop DJ, (2005) Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proceedings of the National Academy of Sciences of the United States of America 102: 18171-18176.
61. Susaki Y, Shimizu S, Katakura K, Watanabe N, Kawamoto K, et al. (1996) Functional properties of murine macrophages promoted by nerve growth factor. Blood 88: 4630-4637.
62. Liuzzo JP, Petanceska SS, Devi LA, (1999) Neurotrophic factors regulate cathepsin S in macrophages and microglia: A role in the degradation of myelin basic protein and amyloid beta peptide. Molecular Medicine 5: 334-343.
63. Rabchevsky AG, Streit WJ, (1998) Role of microglia in postinjury repair and regeneration of the CNS. Mental Retardation and Developmental Disabilities Research Reviews 4: 187-192.
64. Crigler L, Robey RC, Asawachaicharn A, Gaupp D, Phinney DG, (2006) Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Experimental Neurology 198: 54-64.
65. Kurozumi K, Nakamura K, Tamiya T, Kawano Y, Ishii K, et al. (2005) Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther 11: 96-104.
66. Sasaki M, Radtke C, Tan AM, Zhao P, Hamada H, et al. (2009) BDNF-hypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury. Journal of Neuroscience 29: 14932-14941.
67. Jain A, McKeon RJ, Brady-Kalnay SM, Bellamkonda RV, (2011) Sustained delivery of activated Rho GTPases and BDNF promotes axon growth in CSPG-rich regions following spinal cord injury. PLoS One 6: e16135.
68. Ohta M, Suzuki Y, Noda T, Ejiri Y, Dezawa M, et al. (2004) Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Experimental Neurology 187: 266-278.
69. Zurita M, Vaquero J, (2004) Functional recovery in chronic paraplegia after bone marrow stromal cells transplantation. Neuroreport 15: 1105-1108.
70. Nandoe Tewarie RD, Hurtado A, Ritfeld GJ, Rahiem ST, Wendell DF, et al. (2009) Bone marrow stromal cells elicit tissue sparing after acute but not delayed transplantation into the contused adult rat thoracic spinal cord. Journal of Neurotrauma 26: 2313-2322.
71. Samdani AF, Paul C, Betz RR, Fischer I, Neuhuber B, (2009) Transplantation of human marrow stromal cells and mono-nuclear bone marrow cells into the injured spinal cord: a comparative study. Spine (Phila Pa 1976) 34: 2605-2612.
72. Potapova IA, Gaudette GR, Brink PR, Robinson RB, Rosen MR, et al. (2007) Mesenchymal Stem Cells Support Migration, Extracellular Matrix Invasion, Proliferation, and Survival of Endothelial Cells In Vitro. Stem Cells 25: 1761-1768.
73. Lutton C, Young YW, Williams R, Meedeniya AC, Mackay-Sim A, et al. (2011) Combined VEGF and PDGF Treatment Reduces Secondary Degeneration after Spinal Cord Injury. J Neurotrauma.
74. Sundberg LM, Herrera JJ, Narayana PA, (2011) Effect of vascular endothelial growth factor treatment in experimental traumatic spinal cord injury: in vivo longitudinal assessment. J Neurotrauma 28: 565-578.
75. Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, et al. (2004) Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circulation Research 94: 678-685.
76. Sinescu C, Popa F, Grigorean VT, Onose G, Sandu AM, et al. (2010) Molecular basis of vascular events following spinal cord injury. J Med Life 3: 254-261.
77. Mautes AE, Weinzierl MR, Donovan F, Noble LJ, (2000) Vascular events after spinal cord injury: contribution to secondary pathogenesis. Physical Therapy 80: 673-687.
78. Neuhuber B, Swanger S, Howard L, Mackay A, Fischer I, (2008) Effects of plating density and culture time on bone marrow stromal cell characteristics. Experimental Hematology 36: 1176-1185.
79. Jansen BJ, Gilissen C, Roelofs H, Schaap-Oziemlak A, Veltman JA, et al. (2010) Functional differences between mesenchymal stem cell populations are reflected by their transcriptome. Stem Cells Dev 19: 481-490.
80. Bakondi B, Shimada IS, Perry A, Munoz JR, Ylostalo J, et al. (2009) CD133 Identifies a Human Bone Marrow Stem/Progenitor Cell Sub-population With a Repertoire of Secreted Factors That Protect Against Stroke. Mol Ther 17: 1938-1947.
81. Morikawa S, Mabuchi Y, Niibe K, Suzuki S, Nagoshi N, et al. (2009) Development of mesenchymal stem cells partially originate from the neural crest. Biochem Biophys Res Commun 379: 1114-1119.
82. Nagoshi N, Shibata S, Kubota Y, Nakamura M, Nagai Y, et al. (2008) Ontogeny and multipotency of neural crest-derived stem cells in mouse bone marrow, dorsal root ganglia, and whisker pad. Cell Stem Cell 2: 392-403.
83. Sauerzweig S, Munsch T, Lemann V, Reymann KG, Braun H, (2009) A population of serumdeprivation-induced bone marrow stem cells (SD-BMSC) expresses marker typical for embryonic and neural stem cells. Experimental Cell Research 315: 50-66.
84. Wislet-Gendebien S, Leprince P, Moonen G, Rogister B, (2003) Regulation of neural markers nestin and GFAP expression by cultivated bone marrow stromal cells. Journal of Cell Science 116: 3295-3302.
85. Grayson W, Zhao F, Bunnell B, Ma T, (2007) Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells{star, open}. Biochemical and Biophysical Research Communications 358: 948-953.
86. Neuhuber B, Timothy Himes B, Shumsky JS, Gallo G, Fischer I, (2005) Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations. Brain Research 1035: 73-85.
87. Siddappa R, Licht R, van Blitterswijk C, de Boer J, (2007) Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering. Journal of Orthopaedic Research 25: 1029-1041.
88. Tator CH, Fehlings MG, (1991) Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. Journal of Neurosurgery 75: 15-26.
89. Vanicky I, Urdzikova L, Saganova K, Cizkova D, Galik J, (2001) A simple and reproducible model of spinal cord injury induced by epidural balloon inflation in the rat. J Neurotrauma 18: 1399-1407.
90. Basso DM, Beattie MS, Bresnahan JC, (1995) A sensitive and reliable locomotor rating scale for open field testing in rats. Journal of Neurotrauma 12: 1-21.